Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience

BACKGROUND: Real-world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited. OBJECTIVE: To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance, and Ar...

Full description

Bibliographic Details
Published in:Journal of Arrhythmia
Main Authors: Tan, Min Choon, Tan, Jian Liang, Lee, Wei Jun, Srivathsan, Komandoor, Sorajja, Dan, El Masry, Hicham, Scott, Luis R, Lee, Justin Z
Format: Article in Journal/Newspaper
Language:unknown
Published: Touro Scholar 2023
Subjects:
Online Access:https://touroscholar.touro.edu/nymc_res_pubs/310
https://doi.org/10.1002/joa3.12898
https://onlinelibrary.wiley.com/doi/10.1002/joa3.12898
id fttourocollege:oai:touroscholar.touro.edu:nymc_res_pubs-1196
record_format openpolar
spelling fttourocollege:oai:touroscholar.touro.edu:nymc_res_pubs-1196 2024-05-19T07:35:22+00:00 Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience Tan, Min Choon Tan, Jian Liang Lee, Wei Jun Srivathsan, Komandoor Sorajja, Dan El Masry, Hicham Scott, Luis R Lee, Justin Z 2023-10-01T07:00:00Z https://touroscholar.touro.edu/nymc_res_pubs/310 https://doi.org/10.1002/joa3.12898 https://onlinelibrary.wiley.com/doi/10.1002/joa3.12898 unknown Touro Scholar https://touroscholar.touro.edu/nymc_res_pubs/310 doi:10.1002/joa3.12898 https://onlinelibrary.wiley.com/doi/10.1002/joa3.12898 NYMC Residents/Fellows Publications Resident/Fellow Medicine and Health Sciences article 2023 fttourocollege https://doi.org/10.1002/joa3.12898 2024-04-21T23:42:33Z BACKGROUND: Real-world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited. OBJECTIVE: To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance, and Arctic Front Advance Pro) reported in the Food and Drug Administration's (FDA) Manufacturers and User Defined Experience (MAUDE) database. METHODS: We reviewed all the adverse events reported to the FDA MAUDE database over a 10.7-year study period from January 01, 2011 to September 31, 2021. All events were independently reviewed by two physicians. RESULTS: During the study period, a total of 320 procedural-related adverse events reported in the MAUDE database were identified. The most common adverse event was transient or persistent phrenic nerve palsy (PNP), accounting for 48% of all events. This was followed by cardiac perforation (15%), pulmonary vein stenosis (8%), transient ischemic attack or stroke (6%), vascular injury (4%), transient or persistent ST-elevation myocardial infarction (3%), hemoptysis (2%), pericarditis (2%), and esophageal ulcer or fistula (1%). There were six reported intra-procedural death events as a result of cardiac perforation. CONCLUSION: The two most common procedural adverse events associated with cryoballoon ablation were PNP and cardiac perforation. All cases of procedural mortality were due to cardiac perforation. Article in Journal/Newspaper Arctic Touro College & University System: Touro Scholar Journal of Arrhythmia 39 5 784 789
institution Open Polar
collection Touro College & University System: Touro Scholar
op_collection_id fttourocollege
language unknown
topic Resident/Fellow
Medicine and Health Sciences
spellingShingle Resident/Fellow
Medicine and Health Sciences
Tan, Min Choon
Tan, Jian Liang
Lee, Wei Jun
Srivathsan, Komandoor
Sorajja, Dan
El Masry, Hicham
Scott, Luis R
Lee, Justin Z
Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
topic_facet Resident/Fellow
Medicine and Health Sciences
description BACKGROUND: Real-world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited. OBJECTIVE: To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance, and Arctic Front Advance Pro) reported in the Food and Drug Administration's (FDA) Manufacturers and User Defined Experience (MAUDE) database. METHODS: We reviewed all the adverse events reported to the FDA MAUDE database over a 10.7-year study period from January 01, 2011 to September 31, 2021. All events were independently reviewed by two physicians. RESULTS: During the study period, a total of 320 procedural-related adverse events reported in the MAUDE database were identified. The most common adverse event was transient or persistent phrenic nerve palsy (PNP), accounting for 48% of all events. This was followed by cardiac perforation (15%), pulmonary vein stenosis (8%), transient ischemic attack or stroke (6%), vascular injury (4%), transient or persistent ST-elevation myocardial infarction (3%), hemoptysis (2%), pericarditis (2%), and esophageal ulcer or fistula (1%). There were six reported intra-procedural death events as a result of cardiac perforation. CONCLUSION: The two most common procedural adverse events associated with cryoballoon ablation were PNP and cardiac perforation. All cases of procedural mortality were due to cardiac perforation.
format Article in Journal/Newspaper
author Tan, Min Choon
Tan, Jian Liang
Lee, Wei Jun
Srivathsan, Komandoor
Sorajja, Dan
El Masry, Hicham
Scott, Luis R
Lee, Justin Z
author_facet Tan, Min Choon
Tan, Jian Liang
Lee, Wei Jun
Srivathsan, Komandoor
Sorajja, Dan
El Masry, Hicham
Scott, Luis R
Lee, Justin Z
author_sort Tan, Min Choon
title Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_short Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_full Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_fullStr Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_full_unstemmed Adverse Events in Cryoballoon Ablation for Pulmonary Vein Isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_sort adverse events in cryoballoon ablation for pulmonary vein isolation: insight from the food and drug administration manufacturer and user facility device experience
publisher Touro Scholar
publishDate 2023
url https://touroscholar.touro.edu/nymc_res_pubs/310
https://doi.org/10.1002/joa3.12898
https://onlinelibrary.wiley.com/doi/10.1002/joa3.12898
genre Arctic
genre_facet Arctic
op_source NYMC Residents/Fellows Publications
op_relation https://touroscholar.touro.edu/nymc_res_pubs/310
doi:10.1002/joa3.12898
https://onlinelibrary.wiley.com/doi/10.1002/joa3.12898
op_doi https://doi.org/10.1002/joa3.12898
container_title Journal of Arrhythmia
container_volume 39
container_issue 5
container_start_page 784
op_container_end_page 789
_version_ 1799474011040645120